Goldman Sachs Group Inc Nkarta, Inc. Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 600,857 shares of NKTX stock, worth $901,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600,857
Previous 423,233 41.97%
Holding current value
$901,285
Previous $1.91 Million 21.8%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$2.17 - $4.34 $385,444 - $770,888
177,624 Added 41.97%
600,857 $1.5 Million
Q3 2024

Nov 14, 2024
BUY
$4.52 - $8.0 $912,267 - $1.61 Million
201,829 Added 91.16%
423,233 $1.91 Million
Q2 2024

Aug 13, 2024
BUY
$5.27 - $10.82 $889,554 - $1.83 Million
168,796 Added 320.86%
221,404 $1.31 Million
Q1 2024

May 15, 2024
SELL
$5.59 - $15.71 $148,470 - $417,257
-26,560 Reduced 33.55%
52,608 $568,000
Q4 2023

Feb 13, 2024
BUY
$1.31 - $6.6 $10,047 - $50,622
7,670 Added 10.73%
79,168 $522,000
Q3 2023

May 14, 2024
SELL
$1.39 - $2.29 $10,661 - $17,564
-7,670 Reduced 9.69%
71,498 $99,000
Q3 2023

Nov 14, 2023
SELL
$1.39 - $2.29 $33,129 - $54,579
-23,834 Reduced 25.0%
71,498 $99,000
Q2 2023

May 14, 2024
BUY
$2.19 - $5.17 $73,054 - $172,460
33,358 Added 53.83%
95,332 $208,000
Q2 2023

Aug 14, 2023
BUY
$2.19 - $5.17 $73,054 - $172,460
33,358 Added 53.83%
95,332 $208,000
Q1 2023

May 14, 2024
SELL
$3.37 - $6.3 $122,812 - $229,590
-36,443 Reduced 37.03%
61,974 $220,000
Q1 2023

May 11, 2023
SELL
$3.37 - $6.3 $122,812 - $229,590
-36,443 Reduced 37.03%
61,974 $220,000
Q4 2022

May 14, 2024
SELL
$5.14 - $14.35 $444,692 - $1.24 Million
-86,516 Reduced 46.78%
98,417 $589,000
Q4 2022

Feb 13, 2023
SELL
$5.14 - $14.35 $444,692 - $1.24 Million
-86,516 Reduced 46.78%
98,417 $589,000
Q3 2022

May 14, 2024
SELL
$12.27 - $18.39 $395,547 - $592,838
-32,237 Reduced 14.84%
184,933 $2.43 Million
Q3 2022

Nov 10, 2022
SELL
$12.27 - $18.39 $395,547 - $592,838
-32,237 Reduced 14.84%
184,933 $2.43 Million
Q2 2022

May 14, 2024
BUY
$7.77 - $19.44 $1.07 Million - $2.68 Million
138,002 Added 174.32%
217,170 $2.68 Million
Q2 2022

Aug 15, 2022
BUY
$7.77 - $19.44 $768,320 - $1.92 Million
98,883 Added 83.6%
217,170 $2.68 Million
Q1 2022

May 16, 2022
SELL
$8.66 - $14.99 $218,543 - $378,287
-25,236 Reduced 17.58%
118,287 $1.35 Million
Q4 2021

Feb 14, 2022
SELL
$12.79 - $26.88 $1.15 Million - $2.42 Million
-90,165 Reduced 38.58%
143,523 $2.2 Million
Q3 2021

Nov 10, 2021
BUY
$26.67 - $38.76 $6.23 Million - $9.06 Million
233,688 New
233,688 $6.5 Million

Others Institutions Holding NKTX

# of Institutions
120
Shares Held
61.3M
Call Options Held
17.6K
Put Options Held
1.11M
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $73M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email